Global Hereditary Transthyretin Amyloidosis (HATTR) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
According to our (Global Info Research) latest study, the global Hereditary Transthyretin Amyloidosis (HATTR) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Hereditary Transthyretin Amyloidosis (HATTR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hereditary Transthyretin Amyloidosis (HATTR)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hereditary Transthyretin Amyloidosis (HATTR) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena and Lonis Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Hereditary Transthyretin Amyloidosis (HATTR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Hereditary Transthyretin Amyloidosis (HATTR) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hereditary Transthyretin Amyloidosis (HATTR), with revenue, gross margin and global market share of Hereditary Transthyretin Amyloidosis (HATTR) from 2018 to 2023.
Chapter 3, the Hereditary Transthyretin Amyloidosis (HATTR) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hereditary Transthyretin Amyloidosis (HATTR) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Transthyretin Amyloidosis (HATTR).
Chapter 13, to describe Hereditary Transthyretin Amyloidosis (HATTR) research findings and conclusion.
According to our (Global Info Research) latest study, the global Hereditary Transthyretin Amyloidosis (HATTR) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Hereditary Transthyretin Amyloidosis (HATTR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hereditary Transthyretin Amyloidosis (HATTR) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hereditary Transthyretin Amyloidosis (HATTR)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hereditary Transthyretin Amyloidosis (HATTR) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena and Lonis Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Hereditary Transthyretin Amyloidosis (HATTR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- Subcutaneous Injection
- Others
- Hospital
- Clinic
- Others
- Pfizer
- Alnylam Pharmaceuticals
- Akcea Therapeutics
- Prothena
- Lonis Pharmaceuticals
- Eidos Therapeutics
- Corino Therapeutics Inc
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hereditary Transthyretin Amyloidosis (HATTR) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hereditary Transthyretin Amyloidosis (HATTR), with revenue, gross margin and global market share of Hereditary Transthyretin Amyloidosis (HATTR) from 2018 to 2023.
Chapter 3, the Hereditary Transthyretin Amyloidosis (HATTR) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hereditary Transthyretin Amyloidosis (HATTR) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Transthyretin Amyloidosis (HATTR).
Chapter 13, to describe Hereditary Transthyretin Amyloidosis (HATTR) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hereditary Transthyretin Amyloidosis (HATTR)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Transthyretin Amyloidosis (HATTR) by Type
1.3.1 Overview: Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Subcutaneous Injection
1.3.5 Others
1.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market by Application
1.4.1 Overview: Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size & Forecast
1.6 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast by Region
1.6.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region, (2018-2029)
1.6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.6 South America Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.1.4 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Alnylam Pharmaceuticals
2.2.1 Alnylam Pharmaceuticals Details
2.2.2 Alnylam Pharmaceuticals Major Business
2.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.2.4 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.3 Akcea Therapeutics
2.3.1 Akcea Therapeutics Details
2.3.2 Akcea Therapeutics Major Business
2.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.3.4 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Akcea Therapeutics Recent Developments and Future Plans
2.4 Prothena
2.4.1 Prothena Details
2.4.2 Prothena Major Business
2.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.4.4 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Prothena Recent Developments and Future Plans
2.5 Lonis Pharmaceuticals
2.5.1 Lonis Pharmaceuticals Details
2.5.2 Lonis Pharmaceuticals Major Business
2.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.5.4 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lonis Pharmaceuticals Recent Developments and Future Plans
2.6 Eidos Therapeutics
2.6.1 Eidos Therapeutics Details
2.6.2 Eidos Therapeutics Major Business
2.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.6.4 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eidos Therapeutics Recent Developments and Future Plans
2.7 Corino Therapeutics Inc
2.7.1 Corino Therapeutics Inc Details
2.7.2 Corino Therapeutics Inc Major Business
2.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.7.4 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Corino Therapeutics Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hereditary Transthyretin Amyloidosis (HATTR) by Company Revenue
3.2.2 Top 3 Hereditary Transthyretin Amyloidosis (HATTR) Players Market Share in 2022
3.2.3 Top 6 Hereditary Transthyretin Amyloidosis (HATTR) Players Market Share in 2022
3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market: Overall Company Footprint Analysis
3.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market: Region Footprint
3.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Type Footprint
3.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2023)
5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
6.3.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
6.3.2 United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
6.3.3 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
6.3.4 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
7.3.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
7.3.2 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.3 France Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.5 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.6 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region
8.3.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2029)
8.3.2 China Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.3 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.4 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.5 India Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.7 Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
9.2 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
9.3 South America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
9.3.1 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
9.3.2 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
9.3.3 Argentina Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
10.3.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
10.3.2 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10.3.4 UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
11.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
11.3 Hereditary Transthyretin Amyloidosis (HATTR) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Chain
12.2 Hereditary Transthyretin Amyloidosis (HATTR) Upstream Analysis
12.3 Hereditary Transthyretin Amyloidosis (HATTR) Midstream Analysis
12.4 Hereditary Transthyretin Amyloidosis (HATTR) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Hereditary Transthyretin Amyloidosis (HATTR)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Transthyretin Amyloidosis (HATTR) by Type
1.3.1 Overview: Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Subcutaneous Injection
1.3.5 Others
1.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market by Application
1.4.1 Overview: Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size & Forecast
1.6 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast by Region
1.6.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region, (2018-2029)
1.6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.6 South America Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.1.4 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Alnylam Pharmaceuticals
2.2.1 Alnylam Pharmaceuticals Details
2.2.2 Alnylam Pharmaceuticals Major Business
2.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.2.4 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.3 Akcea Therapeutics
2.3.1 Akcea Therapeutics Details
2.3.2 Akcea Therapeutics Major Business
2.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.3.4 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Akcea Therapeutics Recent Developments and Future Plans
2.4 Prothena
2.4.1 Prothena Details
2.4.2 Prothena Major Business
2.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.4.4 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Prothena Recent Developments and Future Plans
2.5 Lonis Pharmaceuticals
2.5.1 Lonis Pharmaceuticals Details
2.5.2 Lonis Pharmaceuticals Major Business
2.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.5.4 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lonis Pharmaceuticals Recent Developments and Future Plans
2.6 Eidos Therapeutics
2.6.1 Eidos Therapeutics Details
2.6.2 Eidos Therapeutics Major Business
2.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.6.4 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eidos Therapeutics Recent Developments and Future Plans
2.7 Corino Therapeutics Inc
2.7.1 Corino Therapeutics Inc Details
2.7.2 Corino Therapeutics Inc Major Business
2.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
2.7.4 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Corino Therapeutics Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hereditary Transthyretin Amyloidosis (HATTR) by Company Revenue
3.2.2 Top 3 Hereditary Transthyretin Amyloidosis (HATTR) Players Market Share in 2022
3.2.3 Top 6 Hereditary Transthyretin Amyloidosis (HATTR) Players Market Share in 2022
3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market: Overall Company Footprint Analysis
3.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market: Region Footprint
3.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Type Footprint
3.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2023)
5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
6.3.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
6.3.2 United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
6.3.3 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
6.3.4 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
7.3.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
7.3.2 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.3 France Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.5 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
7.3.6 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region
8.3.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2029)
8.3.2 China Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.3 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.4 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.5 India Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
8.3.7 Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
9.2 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
9.3 South America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
9.3.1 South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
9.3.2 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
9.3.3 Argentina Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
10.3.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2029)
10.3.2 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
10.3.4 UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
11.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
11.3 Hereditary Transthyretin Amyloidosis (HATTR) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Chain
12.2 Hereditary Transthyretin Amyloidosis (HATTR) Upstream Analysis
12.3 Hereditary Transthyretin Amyloidosis (HATTR) Midstream Analysis
12.4 Hereditary Transthyretin Amyloidosis (HATTR) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 8. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Alnylam Pharmaceuticals Major Business
Table 12. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 13. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 15. Akcea Therapeutics Company Information, Head Office, and Major Competitors
Table 16. Akcea Therapeutics Major Business
Table 17. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 18. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Akcea Therapeutics Recent Developments and Future Plans
Table 20. Prothena Company Information, Head Office, and Major Competitors
Table 21. Prothena Major Business
Table 22. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 23. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Prothena Recent Developments and Future Plans
Table 25. Lonis Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Lonis Pharmaceuticals Major Business
Table 27. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 28. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Lonis Pharmaceuticals Recent Developments and Future Plans
Table 30. Eidos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Eidos Therapeutics Major Business
Table 32. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 33. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eidos Therapeutics Recent Developments and Future Plans
Table 35. Corino Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 36. Corino Therapeutics Inc Major Business
Table 37. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 38. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Corino Therapeutics Inc Recent Developments and Future Plans
Table 40. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million) by Players (2018-2023)
Table 41. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Players (2018-2023)
Table 42. Breakdown of Hereditary Transthyretin Amyloidosis (HATTR) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Hereditary Transthyretin Amyloidosis (HATTR), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key Hereditary Transthyretin Amyloidosis (HATTR) Players
Table 45. Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Type Footprint
Table 46. Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Application Footprint
Table 47. Hereditary Transthyretin Amyloidosis (HATTR) New Market Entrants and Barriers to Market Entry
Table 48. Hereditary Transthyretin Amyloidosis (HATTR) Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Type (2018-2023)
Table 51. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Forecast by Type (2024-2029)
Table 52. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023)
Table 53. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Forecast by Application (2024-2029)
Table 54. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 84. Hereditary Transthyretin Amyloidosis (HATTR) Raw Material
Table 85. Key Suppliers of Hereditary Transthyretin Amyloidosis (HATTR) Raw Materials
Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 8. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Alnylam Pharmaceuticals Major Business
Table 12. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 13. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 15. Akcea Therapeutics Company Information, Head Office, and Major Competitors
Table 16. Akcea Therapeutics Major Business
Table 17. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 18. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Akcea Therapeutics Recent Developments and Future Plans
Table 20. Prothena Company Information, Head Office, and Major Competitors
Table 21. Prothena Major Business
Table 22. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 23. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Prothena Recent Developments and Future Plans
Table 25. Lonis Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Lonis Pharmaceuticals Major Business
Table 27. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 28. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Lonis Pharmaceuticals Recent Developments and Future Plans
Table 30. Eidos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Eidos Therapeutics Major Business
Table 32. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 33. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eidos Therapeutics Recent Developments and Future Plans
Table 35. Corino Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 36. Corino Therapeutics Inc Major Business
Table 37. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Solutions
Table 38. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Corino Therapeutics Inc Recent Developments and Future Plans
Table 40. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (USD Million) by Players (2018-2023)
Table 41. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Players (2018-2023)
Table 42. Breakdown of Hereditary Transthyretin Amyloidosis (HATTR) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Hereditary Transthyretin Amyloidosis (HATTR), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key Hereditary Transthyretin Amyloidosis (HATTR) Players
Table 45. Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Type Footprint
Table 46. Hereditary Transthyretin Amyloidosis (HATTR) Market: Company Product Application Footprint
Table 47. Hereditary Transthyretin Amyloidosis (HATTR) New Market Entrants and Barriers to Market Entry
Table 48. Hereditary Transthyretin Amyloidosis (HATTR) Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Type (2018-2023)
Table 51. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Forecast by Type (2024-2029)
Table 52. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023)
Table 53. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Forecast by Application (2024-2029)
Table 54. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Country (2024-2029) & (USD Million)
Table 84. Hereditary Transthyretin Amyloidosis (HATTR) Raw Material
Table 85. Key Suppliers of Hereditary Transthyretin Amyloidosis (HATTR) Raw Materials
LIST OF FIGURES
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Picture
Figure 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Subcutaneous Injection
Figure 6. Others
Figure 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region in 2022
Figure 17. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Players in 2022
Figure 23. Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Hereditary Transthyretin Amyloidosis (HATTR) Market Share in 2022
Figure 25. Global Top 6 Players Hereditary Transthyretin Amyloidosis (HATTR) Market Share in 2022
Figure 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Type (2018-2023)
Figure 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share Forecast by Type (2024-2029)
Figure 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Application (2018-2023)
Figure 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share Forecast by Application (2024-2029)
Figure 30. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 40. France Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region (2018-2029)
Figure 47. China Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 50. India Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 64. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
Figure 65. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
Figure 66. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Hereditary Transthyretin Amyloidosis (HATTR) in 2022
Figure 69. Manufacturing Process Analysis of Hereditary Transthyretin Amyloidosis (HATTR)
Figure 70. Hereditary Transthyretin Amyloidosis (HATTR) Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Picture
Figure 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type in 2022
Figure 4. Oral
Figure 5. Subcutaneous Injection
Figure 6. Others
Figure 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region in 2022
Figure 17. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Players in 2022
Figure 23. Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Hereditary Transthyretin Amyloidosis (HATTR) Market Share in 2022
Figure 25. Global Top 6 Players Hereditary Transthyretin Amyloidosis (HATTR) Market Share in 2022
Figure 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Type (2018-2023)
Figure 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share Forecast by Type (2024-2029)
Figure 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Share by Application (2018-2023)
Figure 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share Forecast by Application (2024-2029)
Figure 30. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 40. France Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Region (2018-2029)
Figure 47. China Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 50. India Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Hereditary Transthyretin Amyloidosis (HATTR) Consumption Value (2018-2029) & (USD Million)
Figure 64. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
Figure 65. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
Figure 66. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Hereditary Transthyretin Amyloidosis (HATTR) in 2022
Figure 69. Manufacturing Process Analysis of Hereditary Transthyretin Amyloidosis (HATTR)
Figure 70. Hereditary Transthyretin Amyloidosis (HATTR) Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
